Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04920045 · ClinicalTrials.gov registry record · NA
A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge
A NA study, sponsored by University of Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04920045 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 23 participants.
The verdict
NCT04920045, a NA study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial in which hospitalized patients with anemia are randomized to receive transfusion at: a) Hb\<9g/dL (liberal transfusion strategy), or b) Hb\<7g/dL (restrictive transfusion strategy). We are measuring self-reported fatigability, fatigue, and activity levels at randomization and 7 days post hospital discharge in both trial arms. In a subset of 75 patients in each trial arm (150 total), we will are administering the 6 Minute Walk Test at randomization and 7 days post discharge.
Interventions
- OTHER Red blood cell transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2025-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04920045
The ClinicalTrials.gov registry entry for NCT04920045 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Red blood cell transfusion is the first listed.
NCT04920045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04920045 about?
NCT04920045 is a clinical study titled "A Trial to Assess the Effect of Transfusion Strategies on Fatigability Levels After Hospital Discharge". This study is a randomized controlled trial in which hospitalized patients with anemia are randomized to receive transfusion at: a) Hb\<9g/dL (liberal transfusion strategy), or b) Hb\<7g/dL (restrictive transfusion strategy). We are measuring self-reported fatigability, fatigue, and activity levels ...
What is the current status of trial NCT04920045?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2022-02-01. Estimated completion is 2025-03-26.
What interventions are being tested in trial NCT04920045?
The interventions under investigation include: Red blood cell transfusion (OTHER).
Who is sponsoring clinical trial NCT04920045?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.